Literature DB >> 6163004

Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition.

A Overlack, K O Stumpe, M Kühnert, R Kolloch, C Ressel, I Heck, F Krück.   

Abstract

In low- and normal- renin hypertensive patients, but not in high-renin patients, the acute antihypertensive response to the angiotensin-converting enzyme (ACE) inhibitor captopril was completely blocked by aprotinin-induced kallikrein inhibition. Blood pressure reduction with long-term ACE inhibition could be overcome only in part by aprotinin. It is proposed that in low- and normal-renin hypertension the vasodepressor effect of acute ACE inhibition is mainly due to kinin accumulation. Conversely, in high-renin patients a fall in angiotensin II concentration accounts for the hypotensive response to captopril. From the pressor effect of aprotinin in chronically captopril treated patients it appears that kinins are also involved in the blood pressure reduction with long-term ACE inhibition. The finding that ACE inhibition and kallikrein blockade produced predictable and opposite effects on blood pressure suggests broad participation of changes in depressor kinin production in the control of vascular tone in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163004     DOI: 10.1007/BF01477285

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN.

Authors:  D A MCCARTHY; D E POTTER; E D NICOLAIDES
Journal:  J Pharmacol Exp Ther       Date:  1965-04       Impact factor: 4.030

2.  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

Authors:  D B Case; S A Atlas; J H Laragh; J E Sealey; P A Sullivan; D N McKinstry
Journal:  Prog Cardiovasc Dis       Date:  1978 Nov-Dec       Impact factor: 8.194

3.  The angiotensin I converting enzyme.

Authors:  E G Erdös
Journal:  Fed Proc       Date:  1977-04

4.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

Authors:  D W Cushman; H S Cheung; E F Sabo; M A Ondetti
Journal:  Biochemistry       Date:  1977-12-13       Impact factor: 3.162

5.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

6.  Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone.

Authors:  W Vetter; H Vetter; W Siegenthaler
Journal:  Acta Endocrinol (Copenh)       Date:  1973-11

7.  Activation of a prorenin-like substance in human plasma by trypsin and by urinary kallikrein.

Authors:  J E Sealey; S A Atlas; J H Laragh; N B Oza; J W Ryan
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

8.  Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Authors:  C I Johnston; J A Millar; B P McGrath; P G Matthews
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

9.  Accentuated vascular and endocrine response to SQ 20881 in hypertension.

Authors:  G H Williams; N K Hollenberg
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

10.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

Authors:  S L Swartz; G H Williams; N K Hollenberg; L Levine; R G Dluhy; T J Moore
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  4 in total

1.  Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon.

Authors:  S Miyazaki; K Miura; Y Kasai; K Abe; K Yoshinaga
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

Review 2.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 3.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

4.  The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.

Authors:  G Schwietzer; W Oelkers
Journal:  Klin Wochenschr       Date:  1982-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.